Xspray Pharma licenses patent rights to Handa Therapeutics, secures royalty agreement
Its lead product, Dasynoc, is awaiting FDA approval with a PDUFA date of October 7, 2025
Its lead product, Dasynoc, is awaiting FDA approval with a PDUFA date of October 7, 2025
The collaboration will combine Firstsource’s AI-first approach with Guidehealth’s expertise in value-based care innovation
The CRDMO segment contributed Rs. 452.7 crore, recording a robust 70.5 per cent YoY increase
During the quarter, construction began on a US$ 10 million bioconjugation cGMP suite at NJ Bio’s Princeton site
Medical plastics make up about 25 per cent of the 14,000 tons of waste generated daily in US healthcare facilities
The therapy delivers the full-length ABCA4 protein and has the potential to benefit all patients with ABCA4 mutations
The conference will explore the path to India’s first billion-dollar drug, evolution towards value-based healthcare, biotech breakthroughs, and the role of AI and LLMs in care delivery
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
Reinforcing commitment to ethical and sustainable growth
Subscribe To Our Newsletter & Stay Updated